NMD4C Members Presenting at Cure SMA Canada’s Winter Conference

About this Event, hosted by Cure SMA Canada

Thursday December 10 – Sunday December 13, 2020

Welcome to the Cure SMA Canada national SMA conference!

Cure SMA Canada are excited to be able to provide engaging, diverse, and informative topics for Canada’s SMA community to learn, heal and grow. Together we create an amazing cohesive community, learning from each other and making every tomorrow better than today.

Cure SMA would like to thank their sponsors, presenters and attendees.

NMD4C Presenters:

The NMD4C is excited to see many of its members present at this conference!

  • Mise Ă  jour sur le Risdiplam. Dr. Maryam Oskoui
  • Nusinersen treatment update for adults with SMA. Dr. Erin K. O’Ferrall
  • Care for the Caregiver. Rhonda Teichrob
  • Spinraza – mise Ă  jour pĂ©diatrique. Dr. Nicolas Chrestian
  • Pediatric update on Spinraza. Dr. Hernan Gonorazky
  • Risdiplam update. Dr. Maryam Oskoui
  • Peripheral pathology in SMA: Implications for clinical care (What goes wrong in SMA and how to fix it – lessons learned from recent studies). Dr. Rashmi Kothary
  • Biomarkers for SMA. Dr. Robin Parks
  • Ă€ la recherche du role d’SMN dans les neurones et muscles : une stratĂ©gie pour l’identification de nouvelles cibles thĂ©rapeutiques pour l’Amyotrophie Spinale Infantile. Dr. Jocelyn CĂ´tĂ©
  • Teens/adult transition and the importance of multidisciplinary care. Dr. Aaron Izenberg
  • The Changing Landscape of Respiratory Care for SMA. Dr. Reshma Amin

 

Click Here for the full Agenda

Register Now!

129442995_5326426520716803_4661792078481913206_n

Read next...

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

RQAS logo

Quebec Network RĂ©seau QuĂ©bĂ©coise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C

2024 year in review

NMD4C 2024 Year in Review

This year in review outlines a collection of achievements from the network over the past year.

2025 NM fellowship funding recipients

NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!

Meet the Basic Science Trainee Committee

NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers

The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.